Click for best price
Cancer Cachexia Market Size, Share 2023
Market size in 2022 |
US$ 1660.2 million
|
Forecast Market size by 2029 |
US$ 2187.6 million
|
Growth Rate |
CAGR of 4.0% |
Number of Pages |
64 Pages |
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
This report aims to provide a comprehensive presentation of the global market for Cancer Cachexia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Cachexia. This report contains market size and forecasts of Cancer Cachexia in global, including the following market information:
Global Cancer Cachexia Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Cachexia market was valued at US$ 1660.2 million in 2022 and is projected to reach US$ 2187.6 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Progestogens Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Cachexia include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Cachexia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Cachexia Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Cachexia Market Segment Percentages, by Type, 2022 (%)
Progestogens
Corticosteroids
Combination Therapies
Others
Global Cancer Cachexia Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Cachexia Market Segment Percentages, by Application, 2022 (%)
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
Global Cancer Cachexia Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Cachexia Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Cachexia revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Cachexia revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Cachexia, market overview.
Chapter 2: Global Cancer Cachexia market size in revenue.
Chapter 3: Detailed analysis of Cancer Cachexia company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Cachexia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Cancer Cachexia Market, Global Outlook and Forecast 2023-2029 |
Market size in 2022 |
US$ 1660.2 million
|
Forecast Market size by 2029 |
US$ 2187.6 million
|
Growth Rate |
CAGR of 4.0% |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2022 |
Forecast Year |
2030 |
Number of Pages |
64 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Cachexia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Cachexia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Cachexia Overall Market Size
2.1 Global Cancer Cachexia Market Size: 2022 VS 2029
2.2 Global Cancer Cachexia Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Cachexia Players in Global Market
3.2 Top Global Cancer Cachexia Companies Ranked by Revenue
3.3 Global Cancer Cachexia Revenue by Companies
3.4 Top 3 and Top 5 Cancer Cachexia Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Cachexia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Cachexia Players in Global Market
3.6.1 List of Global Tier 1 Cancer Cachexia Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Cachexia Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Cachexia Market Size Markets, 2022 & 2029
4.1.2 Progestogens
4.1.3 Corticosteroids
4.1.4 Combination Therapies
4.1.5 Others
4.2 By Type - Global Cancer Cachexia Revenue & Forecasts
4.2.1 By Type - Global Cancer Cachexia Revenue, 2018-2023
4.2.2 By Type - Global Cancer Cachexia Revenue, 2024-2029
4.2.3 By Type - Global Cancer Cachexia Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Cachexia Market Size, 2022 & 2029
5.1.2 Hospital Stores
5.1.3 Retails Pharmacy Store
5.1.4 Online Pharmacy
5.2 By Application - Global Cancer Cachexia Revenue & Forecasts
5.2.1 By Application - Global Cancer Cachexia Revenue, 2018-2023
5.2.2 By Application - Global Cancer Cachexia Revenue, 2024-2029
5.2.3 By Application - Global Cancer Cachexia Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Cachexia Market Size, 2022 & 2029
6.2 By Region - Global Cancer Cachexia Revenue & Forecasts
6.2.1 By Region - Global Cancer Cachexia Revenue, 2018-2023
6.2.2 By Region - Global Cancer Cachexia Revenue, 2024-2029
6.2.3 By Region - Global Cancer Cachexia Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Cachexia Revenue, 2018-2029
6.3.2 US Cancer Cachexia Market Size, 2018-2029
6.3.3 Canada Cancer Cachexia Market Size, 2018-2029
6.3.4 Mexico Cancer Cachexia Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Cachexia Revenue, 2018-2029
6.4.2 Germany Cancer Cachexia Market Size, 2018-2029
6.4.3 France Cancer Cachexia Market Size, 2018-2029
6.4.4 U.K. Cancer Cachexia Market Size, 2018-2029
6.4.5 Italy Cancer Cachexia Market Size, 2018-2029
6.4.6 Russia Cancer Cachexia Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Cachexia Market Size, 2018-2029
6.4.8 Benelux Cancer Cachexia Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Cachexia Revenue, 2018-2029
6.5.2 China Cancer Cachexia Market Size, 2018-2029
6.5.3 Japan Cancer Cachexia Market Size, 2018-2029
6.5.4 South Korea Cancer Cachexia Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Cachexia Market Size, 2018-2029
6.5.6 India Cancer Cachexia Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Cachexia Revenue, 2018-2029
6.6.2 Brazil Cancer Cachexia Market Size, 2018-2029
6.6.3 Argentina Cancer Cachexia Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Cachexia Revenue, 2018-2029
6.7.2 Turkey Cancer Cachexia Market Size, 2018-2029
6.7.3 Israel Cancer Cachexia Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Cachexia Market Size, 2018-2029
6.7.5 UAE Cancer Cachexia Market Size, 2018-2029
7 Cancer Cachexia Companies Profiles
7.1 Aeterna Zentaris
7.1.1 Aeterna Zentaris Company Summary
7.1.2 Aeterna Zentaris Business Overview
7.1.3 Aeterna Zentaris Cancer Cachexia Major Product Offerings
7.1.4 Aeterna Zentaris Cancer Cachexia Revenue in Global Market (2018-2023)
7.1.5 Aeterna Zentaris Key News & Latest Developments
7.2 Alder BioPharmaceuticals
7.2.1 Alder BioPharmaceuticals Company Summary
7.2.2 Alder BioPharmaceuticals Business Overview
7.2.3 Alder BioPharmaceuticals Cancer Cachexia Major Product Offerings
7.2.4 Alder BioPharmaceuticals Cancer Cachexia Revenue in Global Market (2018-2023)
7.2.5 Alder BioPharmaceuticals Key News & Latest Developments
7.3 Aphios
7.3.1 Aphios Company Summary
7.3.2 Aphios Business Overview
7.3.3 Aphios Cancer Cachexia Major Product Offerings
7.3.4 Aphios Cancer Cachexia Revenue in Global Market (2018-2023)
7.3.5 Aphios Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Cancer Cachexia Major Product Offerings
7.4.4 Eli Lilly Cancer Cachexia Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 GTx
7.5.1 GTx Company Summary
7.5.2 GTx Business Overview
7.5.3 GTx Cancer Cachexia Major Product Offerings
7.5.4 GTx Cancer Cachexia Revenue in Global Market (2018-2023)
7.5.5 GTx Key News & Latest Developments
7.6 Helsinn
7.6.1 Helsinn Company Summary
7.6.2 Helsinn Business Overview
7.6.3 Helsinn Cancer Cachexia Major Product Offerings
7.6.4 Helsinn Cancer Cachexia Revenue in Global Market (2018-2023)
7.6.5 Helsinn Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Cancer Cachexia Major Product Offerings
7.7.4 Merck Cancer Cachexia Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cancer Cachexia Major Product Offerings
7.8.4 Novartis Cancer Cachexia Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Cachexia Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Cachexia Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 XBiotech
7.10.1 XBiotech Company Summary
7.10.2 XBiotech Business Overview
7.10.3 XBiotech Cancer Cachexia Major Product Offerings
7.10.4 XBiotech Cancer Cachexia Revenue in Global Market (2018-2023)
7.10.5 XBiotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Cachexia Market Opportunities & Trends in Global Market
Table 2. Cancer Cachexia Market Drivers in Global Market
Table 3. Cancer Cachexia Market Restraints in Global Market
Table 4. Key Players of Cancer Cachexia in Global Market
Table 5. Top Cancer Cachexia Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Cachexia Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Cachexia Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Cachexia Product Type
Table 9. List of Global Tier 1 Cancer Cachexia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Cachexia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Cachexia Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Cachexia Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Cachexia Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Cachexia Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Cachexia Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Cachexia Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Cachexia Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Cachexia Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Cachexia Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Cachexia Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Cachexia Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Cachexia Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Cachexia Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Cachexia Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Cachexia Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Cachexia Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Cachexia Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Cachexia Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Cachexia Revenue, (US$, Mn), 2024-2029
Table 30. Aeterna Zentaris Company Summary
Table 31. Aeterna Zentaris Cancer Cachexia Product Offerings
Table 32. Aeterna Zentaris Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 33. Aeterna Zentaris Key News & Latest Developments
Table 34. Alder BioPharmaceuticals Company Summary
Table 35. Alder BioPharmaceuticals Cancer Cachexia Product Offerings
Table 36. Alder BioPharmaceuticals Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 37. Alder BioPharmaceuticals Key News & Latest Developments
Table 38. Aphios Company Summary
Table 39. Aphios Cancer Cachexia Product Offerings
Table 40. Aphios Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 41. Aphios Key News & Latest Developments
Table 42. Eli Lilly Company Summary
Table 43. Eli Lilly Cancer Cachexia Product Offerings
Table 44. Eli Lilly Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly Key News & Latest Developments
Table 46. GTx Company Summary
Table 47. GTx Cancer Cachexia Product Offerings
Table 48. GTx Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 49. GTx Key News & Latest Developments
Table 50. Helsinn Company Summary
Table 51. Helsinn Cancer Cachexia Product Offerings
Table 52. Helsinn Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 53. Helsinn Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Cancer Cachexia Product Offerings
Table 56. Merck Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Cancer Cachexia Product Offerings
Table 60. Novartis Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Cancer Cachexia Product Offerings
Table 64. Bristol-Myers Squibb Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. XBiotech Company Summary
Table 67. XBiotech Cancer Cachexia Product Offerings
Table 68. XBiotech Cancer Cachexia Revenue (US$, Mn) & (2018-2023)
Table 69. XBiotech Key News & Latest Developments
List of Figures
Figure 1. Cancer Cachexia Segment by Type in 2022
Figure 2. Cancer Cachexia Segment by Application in 2022
Figure 3. Global Cancer Cachexia Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Cachexia Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Cachexia Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Cachexia Revenue in 2022
Figure 8. By Type - Global Cancer Cachexia Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Cachexia Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Cachexia Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Cachexia Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Cachexia Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Cachexia Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Cachexia Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Cachexia Revenue Market Share, 2018-2029
Figure 16. US Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Cachexia Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Cachexia Revenue Market Share, 2018-2029
Figure 28. China Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Cachexia Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Cachexia Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Cachexia Revenue, (US$, Mn), 2018-2029
Figure 41. Aeterna Zentaris Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alder BioPharmaceuticals Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aphios Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GTx Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Helsinn Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. XBiotech Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)